Kiora Pharmaceuticals, Inc.

KPRX · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income$0-$2-$2-$4
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$0-$2-$1$2
Other Non-Cash-$1$0$0-$0
Operating Cash Flow-$1-$4-$3-$2
Investing Activities
PP&E Inv.-$0-$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0-$5-$4-$7
Inv. Sales/Matur.$6$5$6$7
Other Inv. Act.$0$0$0$0
Investing Cash Flow$6$1$3$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$0$0$0$0
Forex Effect$0$0$0-$0
Net Chg. in Cash$4-$3-$0-$2
Supplemental Information
Beg. Cash$1$4$4$6
End Cash$6$1$4$4
Free Cash Flow-$1-$4-$3-$2
Kiora Pharmaceuticals, Inc. (KPRX) Financial Statements & Key Stats | AlphaPilot